- Home
- GDTC vs NXGL Comparison
GDTC vs NXGL Comparison
Compare GDTC & NXGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDTC
- NXGL
- Stock Information
- Founded
- GDTC 2018
- NXGL 1997
- Country
- GDTC Singapore
- NXGL United States
- Employees
- GDTC N/A
- NXGL N/A
- Industry
- GDTC Biotechnology: Pharmaceutical Preparations
- NXGL Medical/Dental Instruments
- Sector
- GDTC Health Care
- NXGL Health Care
- Exchange
- GDTC Nasdaq
- NXGL Nasdaq
- Market Cap
- GDTC 21.5M
- NXGL 18.7M
- IPO Year
- GDTC 2023
- NXGL 2021
- Fundamental
- Price
- GDTC $2.03
- NXGL $2.43
- Analyst Decision
- GDTC Buy
- NXGL
- Analyst Count
- GDTC 1
- NXGL 0
- Target Price
- GDTC $5.00
- NXGL N/A
- AVG Volume (30 Days)
- GDTC 13.2K
- NXGL 46.5K
- Earning Date
- GDTC 01-01-0001
- NXGL 11-12-2025
- Dividend Yield
- GDTC N/A
- NXGL N/A
- EPS Growth
- GDTC N/A
- NXGL N/A
- EPS
- GDTC N/A
- NXGL N/A
- Revenue
- GDTC $368,838.00
- NXGL $11,672,000.00
- Revenue This Year
- GDTC $5.37
- NXGL $46.60
- Revenue Next Year
- GDTC N/A
- NXGL $47.96
- P/E Ratio
- GDTC N/A
- NXGL N/A
- Revenue Growth
- GDTC N/A
- NXGL 133.02
- 52 Week Low
- GDTC $1.20
- NXGL $2.10
- 52 Week High
- GDTC $4.05
- NXGL $5.10
- Technical
- Relative Strength Index (RSI)
- GDTC 51.85
- NXGL 53.34
- Support Level
- GDTC N/A
- NXGL $2.15
- Resistance Level
- GDTC $2.27
- NXGL $2.60
- Average True Range (ATR)
- GDTC 0.10
- NXGL 0.17
- MACD
- GDTC -0.06
- NXGL 0.03
- Stochastic Oscillator
- GDTC 87.67
- NXGL 64.00
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
About NXGL NexGel Inc
NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating and cross-linking technologies.